| 1 | develop | 9,576 |
| 2 | survive | 705 |
| 3 | recover | 694 |
| 4 | acquire | 526 |
| 5 | formulate | 312 |
| 6 | devise | 113 |
| 7 | endure | 61 |
| 8 | inherit | 23 |
| 9 | polymerize | 13 |
| 10 | graze | 11 |
| 11 | self-diagnose | 11 |
| 12 | forge | 8 |
| 13 | convene | 5 |
| 14 | encrust | 4 |
| 15 | cauti-specific | 3 |
| 16 | develope | 3 |
| 17 | lute | 3 |
| 18 | 0.8472 | 2 |
| 19 | hucr | 2 |
| 20 | landesman | 2 |
| 21 | ondensetron | 2 |
| 22 | re-colonize | 2 |
| 23 | self-schedule | 2 |
| 24 | 'develop | 1 |
| 25 | -0.19±0.38d | 1 |
| 26 | -0.771 | 1 |
| 27 | -19.2/-15.2 | 1 |
| 28 | -23.7‰ | 1 |
| 29 | -433mmhg | 1 |
| 30 | 0.00162 | 1 |
| 31 | 0.004mg/ml | 1 |
| 32 | 0.00894 | 1 |
| 33 | 0.13- | 1 |
| 34 | 0.19±0.25 | 1 |
| 35 | 0.309w/mk | 1 |
| 36 | 0.33±0.21 | 1 |
| 37 | 0.35±0.62 | 1 |
| 38 | 0.49±0.15 | 1 |
| 39 | 0.674±0.01 | 1 |
| 40 | 0.71+/-0.11 | 1 |
| 41 | 0.7668 | 1 |
| 42 | 0.78571 | 1 |
| 43 | 0.84±0.09 | 1 |
| 44 | 08/31/2010 | 1 |
| 45 | 1,3,4-trcdf | 1 |
| 46 | 1-1.33 | 1 |
| 47 | 1-insp7 | 1 |
| 48 | 1.0546 | 1 |
| 49 | 1.0z | 1 |
| 50 | 1.1717 | 1 |
| 51 | 1.4238 | 1 |
| 52 | 100years | 1 |
| 53 | 10217euro | 1 |
| 54 | 11,261.8 | 1 |
| 55 | 11-month-olds | 1 |
| 56 | 11.26-fold | 1 |
| 57 | 115.2±23.1 | 1 |
| 58 | 118.8+/-6.9 | 1 |
| 59 | 122+/-48 | 1 |
| 60 | 135+/-12mmhg | 1 |
| 61 | 14.0±11.9 | 1 |
| 62 | 142.3±22.9μmol/l | 1 |
| 63 | 15+/-15 | 1 |
| 64 | 15.6±4.5 | 1 |
| 65 | 153.67±20.34 | 1 |
| 66 | 153±10/83±8 | 1 |
| 67 | 176±30 | 1 |
| 68 | 17alpha-hydroxylate | 1 |
| 69 | 18.60±1.18 | 1 |
| 70 | 18.7±0.2 | 1 |
| 71 | 180-fold | 1 |
| 72 | 1846±75 | 1 |
| 73 | 1949» | 1 |
| 74 | 2,2-dialkyl- | 1 |
| 75 | 2-tb | 1 |
| 76 | 2.5+/-0.58 | 1 |
| 77 | 20.7° | 1 |
| 78 | 20/.04 | 1 |
| 79 | 2000μa | 1 |
| 80 | 2002/09 | 1 |
| 81 | 20110822 | 1 |
| 82 | 20:3n-3 | 1 |
| 83 | 20:3ω3 | 1 |
| 84 | 21.4±0.8 | 1 |
| 85 | 22.3microg/ml | 1 |
| 86 | 22.8+/-29.6 | 1 |
| 87 | 23-month-olds | 1 |
| 88 | 24,206 | 1 |
| 89 | 282mosmol/kg | 1 |
| 90 | 292,666 | 1 |
| 91 | 299.8±54.5 | 1 |
| 92 | 3,4-dihydro-2h-benzo- | 1 |
| 93 | 3-hydroxylaminonitrobenzene | 1 |
| 94 | 3.15.1989 | 1 |
| 95 | 310.8°c | 1 |
| 96 | 33.3-fold | 1 |
| 97 | 34.12 | 1 |
| 98 | 35.2±21.8 | 1 |
| 99 | 368°c | 1 |
| 100 | 38.8-fold | 1 |
| 101 | 38±1°c | 1 |
| 102 | 3wu | 1 |
| 103 | 4.1-log | 1 |
| 104 | 4.9±2.8 | 1 |
| 105 | 40.4ppmv | 1 |
| 106 | 45,800/mm3 | 1 |
| 107 | 478.2 | 1 |
| 108 | 48-h-olds | 1 |
| 109 | 494°/s | 1 |
| 110 | 4s-pathway | 1 |
| 111 | 5.89+/-0.59 | 1 |
| 112 | 520.5+/-87.3 | 1 |
| 113 | 54.8±7.3 | 1 |
| 114 | 57.1±1.1 | 1 |
| 115 | 5beta-pregnane-3alpha/3beta,17alpha,20alpha-triols | 1 |
| 116 | 6.2μm | 1 |
| 117 | 6.6±3 | 1 |
| 118 | 60.6° | 1 |
| 119 | 60±27.5 | 1 |
| 120 | 62.1+/-11.0 | 1 |
| 121 | 677cc-mthfr | 1 |
| 122 | 6860 | 1 |
| 123 | 6±1.06 | 1 |
| 124 | 7.94±1.8 | 1 |
| 125 | 71+/-2 | 1 |
| 126 | 720nm | 1 |
| 127 | 75.0±16.2 | 1 |
| 128 | 753.46+/-53.34 | 1 |
| 129 | 8.9+/-1.6 | 1 |
| 130 | 8:1000 | 1 |
| 131 | 9.1/24 | 1 |
| 132 | 90,735 | 1 |
| 133 | 91,219 | 1 |
| 134 | aché | 1 |
| 135 | actidione | 1 |
| 136 | actn3rr | 1 |
| 137 | addresssepsis | 1 |
| 138 | al-assad | 1 |
| 139 | amygdalostriatal | 1 |
| 140 | antiallergenics | 1 |
| 141 | anxiety/calmness | 1 |
| 142 | apolipoprotein-based | 1 |
| 143 | appetite-regulation | 1 |
| 144 | apprise | 1 |
| 145 | arome | 1 |
| 146 | automimicry | 1 |
| 147 | benchâabane | 1 |
| 148 | bone-pressure | 1 |
| 149 | breddin | 1 |
| 150 | bupivacaine- | 1 |
| 151 | c6-oh | 1 |
| 152 | cab₆ | 1 |
| 153 | carbapenam | 1 |
| 154 | cardiac-remodeling | 1 |
| 155 | cdk10 | 1 |
| 156 | cep170 | 1 |
| 157 | chalumeau | 1 |
| 158 | cinolones | 1 |
| 159 | classifiy | 1 |
| 160 | collec | 1 |
| 161 | consent/enroll | 1 |
| 162 | cotrimoxazole/sulfamethoxazole | 1 |
| 163 | cycloalkanones | 1 |
| 164 | d-penacillamine | 1 |
| 165 | d1/malaysia/36000/05 | 1 |
| 166 | ddp- | 1 |
| 167 | decidualize | 1 |
| 168 | degranulate | 1 |
| 169 | deltapn/year | 1 |
| 170 | devernalization | 1 |
| 171 | diskus™ | 1 |
| 172 | dna-molecules | 1 |
| 173 | dopa-melanin | 1 |
| 174 | dose-de- | 1 |
| 175 | drop-taking | 1 |
| 176 | dropout-rates | 1 |
| 177 | dyspnoea/polypnoea | 1 |
| 178 | e-line | 1 |
| 179 | ebpg | 1 |
| 180 | ecorii | 1 |
| 181 | electrocardiological | 1 |
| 182 | eluciate | 1 |
| 183 | epicentral | 1 |
| 184 | eupafolin | 1 |
| 185 | fe13 | 1 |
| 186 | fg-nups | 1 |
| 187 | five-layers | 1 |
| 188 | fluoroquinolnes | 1 |
| 189 | ghxth1 | 1 |
| 190 | gp-consultations | 1 |
| 191 | graded-calorie | 1 |
| 192 | granddaughters | 1 |
| 193 | guanaco | 1 |
| 194 | gumboro | 1 |
| 195 | halstedianism | 1 |
| 196 | hand-pointing | 1 |
| 197 | hansten | 1 |
| 198 | help/interact | 1 |
| 199 | high-energy- | 1 |
| 200 | hipokaliemia | 1 |
| 201 | hla-a- | 1 |
| 202 | holldack | 1 |
| 203 | hothouses | 1 |
| 204 | hotz | 1 |
| 205 | hurwitz | 1 |
| 206 | hydrochloroquine | 1 |
| 207 | hydrodissect | 1 |
| 208 | hypercalcuria/hypercalcemia | 1 |
| 209 | hyperlactaemia | 1 |
| 210 | hyposenzibilization | 1 |
| 211 | hypoxia-hyperoxia | 1 |
| 212 | ich-e14 | 1 |
| 213 | identify/develop | 1 |
| 214 | ileocecum | 1 |
| 215 | inhalant- | 1 |
| 216 | injecting-drug-users | 1 |
| 217 | intense-relationships | 1 |
| 218 | interpathologist | 1 |
| 219 | intimal-based | 1 |
| 220 | isatin-3-hydrazones | 1 |
| 221 | iso1567 | 1 |
| 222 | iso6872 | 1 |
| 223 | isolator-bedding | 1 |
| 224 | itemize | 1 |
| 225 | j=25 | 1 |
| 226 | jass | 1 |
| 227 | kjelsen | 1 |
| 228 | kohistan | 1 |
| 229 | lactofuchsin | 1 |
| 230 | laryngotracheomalacia | 1 |
| 231 | laser/cryotherapy | 1 |
| 232 | laulimalide | 1 |
| 233 | lee-white | 1 |
| 234 | lep- | 1 |
| 235 | low-plan | 1 |
| 236 | lys444 | 1 |
| 237 | malaria/tb | 1 |
| 238 | malate/pyruvate | 1 |
| 239 | malfermentation | 1 |
| 240 | mammopoiesis | 1 |
| 241 | mcd/oo | 1 |
| 242 | mcq1 | 1 |
| 243 | mdma/mda | 1 |
| 244 | meichenbaum | 1 |
| 245 | meindl | 1 |
| 246 | met8 | 1 |
| 247 | metainflammation | 1 |
| 248 | microaerophiles | 1 |
| 249 | mild-systole | 1 |
| 250 | mineralise | 1 |
| 251 | morning-preference | 1 |
| 252 | morphine/m6g/oxycodone | 1 |
| 253 | motor-preparation | 1 |
| 254 | n-thiophosphorylated | 1 |
| 255 | nanoviruses | 1 |
| 256 | ncl- | 1 |
| 257 | neer- | 1 |
| 258 | neuroimmune-modulation | 1 |
| 259 | nincds-airen | 1 |
| 260 | non-ctos | 1 |
| 261 | non-levodopa | 1 |
| 262 | non-nhl | 1 |
| 263 | non-planners | 1 |
| 264 | non-resistance | 1 |
| 265 | none-mild | 1 |
| 266 | nzrb-g90 | 1 |
| 267 | o-diphenol | 1 |
| 268 | oa.australian | 1 |
| 269 | octatropine-methyl-bromide | 1 |
| 270 | onset-of-thickening | 1 |
| 271 | over-condensation | 1 |
| 272 | overtidiness | 1 |
| 273 | oxymorphone-3-glucuronide | 1 |
| 274 | paleo-indians | 1 |
| 275 | penicilin | 1 |
| 276 | peoscopy | 1 |
| 277 | peri-insulitis | 1 |
| 278 | pharmaco-treatment | 1 |
| 279 | placebo.low-quality | 1 |
| 280 | politicize | 1 |
| 281 | polyubiquitinate | 1 |
| 282 | post-imt | 1 |
| 283 | pre-agreed-on | 1 |
| 284 | pre-concentrate | 1 |
| 285 | preapproved | 1 |
| 286 | pregnancy-loss | 1 |
| 287 | pro-lc3 | 1 |
| 288 | pseudoabsorbance | 1 |
| 289 | radius2/radius3 | 1 |
| 290 | ranke | 1 |
| 291 | remarry | 1 |
| 292 | resveratrol/hydroxycinnamate | 1 |
| 293 | rhabdoviridae | 1 |
| 294 | rosiglitzone | 1 |
| 295 | sad- | 1 |
| 296 | schroeder | 1 |
| 297 | sclerose | 1 |
| 298 | screen/identify | 1 |
| 299 | self-advocate | 1 |
| 300 | self-evolve | 1 |
| 301 | si-miapaca2 | 1 |
| 302 | single-gloved | 1 |
| 303 | snap29 | 1 |
| 304 | splenectomy-based | 1 |
| 305 | standarized | 1 |
| 306 | sunflower- | 1 |
| 307 | supersaturate | 1 |
| 308 | tabagism | 1 |
| 309 | tape-recording | 1 |
| 310 | tetramesityldisilene | 1 |
| 311 | theses-uk | 1 |
| 312 | thionin | 1 |
| 313 | tilted/twisted | 1 |
| 314 | time-to-recovery | 1 |
| 315 | tlr5-independent | 1 |
| 316 | top-notch | 1 |
| 317 | torquing.a | 1 |
| 318 | tossy | 1 |
| 319 | trm.sponsorship | 1 |
| 320 | troponine | 1 |
| 321 | ttv-negative | 1 |
| 322 | u-50,488h | 1 |
| 323 | unwilted | 1 |
| 324 | uv-control | 1 |
| 325 | ventrolateral-orbitofrontal | 1 |
| 326 | vipr2 | 1 |
| 327 | viviparity | 1 |
| 328 | volatile-sulfur | 1 |
| 329 | wet-film | 1 |
| 330 | windfuhr | 1 |
| 331 | zdv- | 1 |
| 332 | zipursky | 1 |
| 333 | £10,926 | 1 |
| 334 | £5,130 | 1 |
| 335 | £75,520 | 1 |
| 336 | £902 | 1 |
| 337 | α-expansins | 1 |
| 338 | β'- | 1 |
| 339 | δbmi≤5 | 1 |
| 340 | €12.37 | 1 |
| 341 | €120,195 | 1 |
| 342 | €41,986 | 1 |
| 343 | €9,044 | 1 |
| 344 | ∼122 | 1 |
| 345 | ≤4.25mm | 1 |
| 346 | ≤71°c | 1 |
| 347 | ≤89- | 1 |
| 1 | 'develop | 1 |
| 2 | -0.19±0.38d | 1 |
| 3 | -0.771 | 1 |
| 4 | -19.2/-15.2 | 1 |
| 5 | -23.7‰ | 1 |
| 6 | -433mmhg | 1 |
| 7 | 0.00162 | 1 |
| 8 | 0.004mg/ml | 1 |
| 9 | 0.00894 | 1 |
| 10 | 0.13- | 1 |
| 11 | 0.19±0.25 | 1 |
| 12 | 0.309w/mk | 1 |
| 13 | 0.33±0.21 | 1 |
| 14 | 0.35±0.62 | 1 |
| 15 | 0.49±0.15 | 1 |
| 16 | 0.674±0.01 | 1 |
| 17 | 0.71+/-0.11 | 1 |
| 18 | 0.7668 | 1 |
| 19 | 0.78571 | 1 |
| 20 | 0.8472 | 2 |
| 21 | 0.84±0.09 | 1 |
| 22 | 08/31/2010 | 1 |
| 23 | 1,3,4-trcdf | 1 |
| 24 | 1-1.33 | 1 |
| 25 | 1-insp7 | 1 |
| 26 | 1.0546 | 1 |
| 27 | 1.0z | 1 |
| 28 | 1.1717 | 1 |
| 29 | 1.4238 | 1 |
| 30 | 100years | 1 |
| 31 | 10217euro | 1 |
| 32 | 11,261.8 | 1 |
| 33 | 11-month-olds | 1 |
| 34 | 11.26-fold | 1 |
| 35 | 115.2±23.1 | 1 |
| 36 | 118.8+/-6.9 | 1 |
| 37 | 122+/-48 | 1 |
| 38 | 135+/-12mmhg | 1 |
| 39 | 14.0±11.9 | 1 |
| 40 | 142.3±22.9μmol/l | 1 |
| 41 | 15+/-15 | 1 |
| 42 | 15.6±4.5 | 1 |
| 43 | 153.67±20.34 | 1 |
| 44 | 153±10/83±8 | 1 |
| 45 | 176±30 | 1 |
| 46 | 17alpha-hydroxylate | 1 |
| 47 | 18.60±1.18 | 1 |
| 48 | 18.7±0.2 | 1 |
| 49 | 180-fold | 1 |
| 50 | 1846±75 | 1 |
| 51 | 1949» | 1 |
| 52 | 2,2-dialkyl- | 1 |
| 53 | 2-tb | 1 |
| 54 | 2.5+/-0.58 | 1 |
| 55 | 20.7° | 1 |
| 56 | 20/.04 | 1 |
| 57 | 2000μa | 1 |
| 58 | 2002/09 | 1 |
| 59 | 20110822 | 1 |
| 60 | 20:3n-3 | 1 |
| 61 | 20:3ω3 | 1 |
| 62 | 21.4±0.8 | 1 |
| 63 | 22.3microg/ml | 1 |
| 64 | 22.8+/-29.6 | 1 |
| 65 | 23-month-olds | 1 |
| 66 | 24,206 | 1 |
| 67 | 282mosmol/kg | 1 |
| 68 | 292,666 | 1 |
| 69 | 299.8±54.5 | 1 |
| 70 | 3,4-dihydro-2h-benzo- | 1 |
| 71 | 3-hydroxylaminonitrobenzene | 1 |
| 72 | 3.15.1989 | 1 |
| 73 | 310.8°c | 1 |
| 74 | 33.3-fold | 1 |
| 75 | 34.12 | 1 |
| 76 | 35.2±21.8 | 1 |
| 77 | 368°c | 1 |
| 78 | 38.8-fold | 1 |
| 79 | 38±1°c | 1 |
| 80 | 3wu | 1 |
| 81 | 4.1-log | 1 |
| 82 | 4.9±2.8 | 1 |
| 83 | 40.4ppmv | 1 |
| 84 | 45,800/mm3 | 1 |
| 85 | 478.2 | 1 |
| 86 | 48-h-olds | 1 |
| 87 | 494°/s | 1 |
| 88 | 4s-pathway | 1 |
| 89 | 5.89+/-0.59 | 1 |
| 90 | 520.5+/-87.3 | 1 |
| 91 | 54.8±7.3 | 1 |
| 92 | 57.1±1.1 | 1 |
| 93 | 5beta-pregnane-3alpha/3beta,17alpha,20alpha-triols | 1 |
| 94 | 6.2μm | 1 |
| 95 | 6.6±3 | 1 |
| 96 | 60.6° | 1 |
| 97 | 60±27.5 | 1 |
| 98 | 62.1+/-11.0 | 1 |
| 99 | 677cc-mthfr | 1 |
| 100 | 6860 | 1 |
| 101 | 6±1.06 | 1 |
| 102 | 7.94±1.8 | 1 |
| 103 | 71+/-2 | 1 |
| 104 | 720nm | 1 |
| 105 | 75.0±16.2 | 1 |
| 106 | 753.46+/-53.34 | 1 |
| 107 | 8.9+/-1.6 | 1 |
| 108 | 8:1000 | 1 |
| 109 | 9.1/24 | 1 |
| 110 | 90,735 | 1 |
| 111 | 91,219 | 1 |
| 112 | aché | 1 |
| 113 | acquire | 526 |
| 114 | actidione | 1 |
| 115 | actn3rr | 1 |
| 116 | addresssepsis | 1 |
| 117 | al-assad | 1 |
| 118 | amygdalostriatal | 1 |
| 119 | antiallergenics | 1 |
| 120 | anxiety/calmness | 1 |
| 121 | apolipoprotein-based | 1 |
| 122 | appetite-regulation | 1 |
| 123 | apprise | 1 |
| 124 | arome | 1 |
| 125 | automimicry | 1 |
| 126 | benchâabane | 1 |
| 127 | bone-pressure | 1 |
| 128 | breddin | 1 |
| 129 | bupivacaine- | 1 |
| 130 | c6-oh | 1 |
| 131 | cab₆ | 1 |
| 132 | carbapenam | 1 |
| 133 | cardiac-remodeling | 1 |
| 134 | cauti-specific | 3 |
| 135 | cdk10 | 1 |
| 136 | cep170 | 1 |
| 137 | chalumeau | 1 |
| 138 | cinolones | 1 |
| 139 | classifiy | 1 |
| 140 | collec | 1 |
| 141 | consent/enroll | 1 |
| 142 | convene | 5 |
| 143 | cotrimoxazole/sulfamethoxazole | 1 |
| 144 | cycloalkanones | 1 |
| 145 | d-penacillamine | 1 |
| 146 | d1/malaysia/36000/05 | 1 |
| 147 | ddp- | 1 |
| 148 | decidualize | 1 |
| 149 | degranulate | 1 |
| 150 | deltapn/year | 1 |
| 151 | develop | 9,576 |
| 152 | develope | 3 |
| 153 | devernalization | 1 |
| 154 | devise | 113 |
| 155 | diskus™ | 1 |
| 156 | dna-molecules | 1 |
| 157 | dopa-melanin | 1 |
| 158 | dose-de- | 1 |
| 159 | drop-taking | 1 |
| 160 | dropout-rates | 1 |
| 161 | dyspnoea/polypnoea | 1 |
| 162 | e-line | 1 |
| 163 | ebpg | 1 |
| 164 | ecorii | 1 |
| 165 | electrocardiological | 1 |
| 166 | eluciate | 1 |
| 167 | encrust | 4 |
| 168 | endure | 61 |
| 169 | epicentral | 1 |
| 170 | eupafolin | 1 |
| 171 | fe13 | 1 |
| 172 | fg-nups | 1 |
| 173 | five-layers | 1 |
| 174 | fluoroquinolnes | 1 |
| 175 | forge | 8 |
| 176 | formulate | 312 |
| 177 | ghxth1 | 1 |
| 178 | gp-consultations | 1 |
| 179 | graded-calorie | 1 |
| 180 | granddaughters | 1 |
| 181 | graze | 11 |
| 182 | guanaco | 1 |
| 183 | gumboro | 1 |
| 184 | halstedianism | 1 |
| 185 | hand-pointing | 1 |
| 186 | hansten | 1 |
| 187 | help/interact | 1 |
| 188 | high-energy- | 1 |
| 189 | hipokaliemia | 1 |
| 190 | hla-a- | 1 |
| 191 | holldack | 1 |
| 192 | hothouses | 1 |
| 193 | hotz | 1 |
| 194 | hucr | 2 |
| 195 | hurwitz | 1 |
| 196 | hydrochloroquine | 1 |
| 197 | hydrodissect | 1 |
| 198 | hypercalcuria/hypercalcemia | 1 |
| 199 | hyperlactaemia | 1 |
| 200 | hyposenzibilization | 1 |
| 201 | hypoxia-hyperoxia | 1 |
| 202 | ich-e14 | 1 |
| 203 | identify/develop | 1 |
| 204 | ileocecum | 1 |
| 205 | inhalant- | 1 |
| 206 | inherit | 23 |
| 207 | injecting-drug-users | 1 |
| 208 | intense-relationships | 1 |
| 209 | interpathologist | 1 |
| 210 | intimal-based | 1 |
| 211 | isatin-3-hydrazones | 1 |
| 212 | iso1567 | 1 |
| 213 | iso6872 | 1 |
| 214 | isolator-bedding | 1 |
| 215 | itemize | 1 |
| 216 | j=25 | 1 |
| 217 | jass | 1 |
| 218 | kjelsen | 1 |
| 219 | kohistan | 1 |
| 220 | lactofuchsin | 1 |
| 221 | landesman | 2 |
| 222 | laryngotracheomalacia | 1 |
| 223 | laser/cryotherapy | 1 |
| 224 | laulimalide | 1 |
| 225 | lee-white | 1 |
| 226 | lep- | 1 |
| 227 | low-plan | 1 |
| 228 | lute | 3 |
| 229 | lys444 | 1 |
| 230 | malaria/tb | 1 |
| 231 | malate/pyruvate | 1 |
| 232 | malfermentation | 1 |
| 233 | mammopoiesis | 1 |
| 234 | mcd/oo | 1 |
| 235 | mcq1 | 1 |
| 236 | mdma/mda | 1 |
| 237 | meichenbaum | 1 |
| 238 | meindl | 1 |
| 239 | met8 | 1 |
| 240 | metainflammation | 1 |
| 241 | microaerophiles | 1 |
| 242 | mild-systole | 1 |
| 243 | mineralise | 1 |
| 244 | morning-preference | 1 |
| 245 | morphine/m6g/oxycodone | 1 |
| 246 | motor-preparation | 1 |
| 247 | n-thiophosphorylated | 1 |
| 248 | nanoviruses | 1 |
| 249 | ncl- | 1 |
| 250 | neer- | 1 |
| 251 | neuroimmune-modulation | 1 |
| 252 | nincds-airen | 1 |
| 253 | non-ctos | 1 |
| 254 | non-levodopa | 1 |
| 255 | non-nhl | 1 |
| 256 | non-planners | 1 |
| 257 | non-resistance | 1 |
| 258 | none-mild | 1 |
| 259 | nzrb-g90 | 1 |
| 260 | o-diphenol | 1 |
| 261 | oa.australian | 1 |
| 262 | octatropine-methyl-bromide | 1 |
| 263 | ondensetron | 2 |
| 264 | onset-of-thickening | 1 |
| 265 | over-condensation | 1 |
| 266 | overtidiness | 1 |
| 267 | oxymorphone-3-glucuronide | 1 |
| 268 | paleo-indians | 1 |
| 269 | penicilin | 1 |
| 270 | peoscopy | 1 |
| 271 | peri-insulitis | 1 |
| 272 | pharmaco-treatment | 1 |
| 273 | placebo.low-quality | 1 |
| 274 | politicize | 1 |
| 275 | polymerize | 13 |
| 276 | polyubiquitinate | 1 |
| 277 | post-imt | 1 |
| 278 | pre-agreed-on | 1 |
| 279 | pre-concentrate | 1 |
| 280 | preapproved | 1 |
| 281 | pregnancy-loss | 1 |
| 282 | pro-lc3 | 1 |
| 283 | pseudoabsorbance | 1 |
| 284 | radius2/radius3 | 1 |
| 285 | ranke | 1 |
| 286 | re-colonize | 2 |
| 287 | recover | 694 |
| 288 | remarry | 1 |
| 289 | resveratrol/hydroxycinnamate | 1 |
| 290 | rhabdoviridae | 1 |
| 291 | rosiglitzone | 1 |
| 292 | sad- | 1 |
| 293 | schroeder | 1 |
| 294 | sclerose | 1 |
| 295 | screen/identify | 1 |
| 296 | self-advocate | 1 |
| 297 | self-diagnose | 11 |
| 298 | self-evolve | 1 |
| 299 | self-schedule | 2 |
| 300 | si-miapaca2 | 1 |
| 301 | single-gloved | 1 |
| 302 | snap29 | 1 |
| 303 | splenectomy-based | 1 |
| 304 | standarized | 1 |
| 305 | sunflower- | 1 |
| 306 | supersaturate | 1 |
| 307 | survive | 705 |
| 308 | tabagism | 1 |
| 309 | tape-recording | 1 |
| 310 | tetramesityldisilene | 1 |
| 311 | theses-uk | 1 |
| 312 | thionin | 1 |
| 313 | tilted/twisted | 1 |
| 314 | time-to-recovery | 1 |
| 315 | tlr5-independent | 1 |
| 316 | top-notch | 1 |
| 317 | torquing.a | 1 |
| 318 | tossy | 1 |
| 319 | trm.sponsorship | 1 |
| 320 | troponine | 1 |
| 321 | ttv-negative | 1 |
| 322 | u-50,488h | 1 |
| 323 | unwilted | 1 |
| 324 | uv-control | 1 |
| 325 | ventrolateral-orbitofrontal | 1 |
| 326 | vipr2 | 1 |
| 327 | viviparity | 1 |
| 328 | volatile-sulfur | 1 |
| 329 | wet-film | 1 |
| 330 | windfuhr | 1 |
| 331 | zdv- | 1 |
| 332 | zipursky | 1 |
| 333 | £10,926 | 1 |
| 334 | £5,130 | 1 |
| 335 | £75,520 | 1 |
| 336 | £902 | 1 |
| 337 | α-expansins | 1 |
| 338 | β'- | 1 |
| 339 | δbmi≤5 | 1 |
| 340 | €12.37 | 1 |
| 341 | €120,195 | 1 |
| 342 | €41,986 | 1 |
| 343 | €9,044 | 1 |
| 344 | ∼122 | 1 |
| 345 | ≤4.25mm | 1 |
| 346 | ≤71°c | 1 |
| 347 | ≤89- | 1 |
| 1 | β'- | 1 |
| 2 | 0.13- | 1 |
| 3 | ≤89- | 1 |
| 4 | hla-a- | 1 |
| 5 | sad- | 1 |
| 6 | dose-de- | 1 |
| 7 | bupivacaine- | 1 |
| 8 | ncl- | 1 |
| 9 | 2,2-dialkyl- | 1 |
| 10 | 3,4-dihydro-2h-benzo- | 1 |
| 11 | ddp- | 1 |
| 12 | lep- | 1 |
| 13 | neer- | 1 |
| 14 | sunflower- | 1 |
| 15 | inhalant- | 1 |
| 16 | zdv- | 1 |
| 17 | high-energy- | 1 |
| 18 | 62.1+/-11.0 | 1 |
| 19 | 8:1000 | 1 |
| 20 | 08/31/2010 | 1 |
| 21 | cdk10 | 1 |
| 22 | £75,520 | 1 |
| 23 | £5,130 | 1 |
| 24 | 176±30 | 1 |
| 25 | 6860 | 1 |
| 26 | cep170 | 1 |
| 27 | nzrb-g90 | 1 |
| 28 | 57.1±1.1 | 1 |
| 29 | 115.2±23.1 | 1 |
| 30 | 0.674±0.01 | 1 |
| 31 | 0.71+/-0.11 | 1 |
| 32 | 0.33±0.21 | 1 |
| 33 | 0.78571 | 1 |
| 34 | -0.771 | 1 |
| 35 | ghxth1 | 1 |
| 36 | mcq1 | 1 |
| 37 | 71+/-2 | 1 |
| 38 | 18.7±0.2 | 1 |
| 39 | -19.2/-15.2 | 1 |
| 40 | 75.0±16.2 | 1 |
| 41 | 478.2 | 1 |
| 42 | £902 | 1 |
| 43 | 34.12 | 1 |
| 44 | ∼122 | 1 |
| 45 | 20110822 | 1 |
| 46 | 0.35±0.62 | 1 |
| 47 | 0.00162 | 1 |
| 48 | 0.8472 | 2 |
| 49 | iso6872 | 1 |
| 50 | si-miapaca2 | 1 |
| 51 | vipr2 | 1 |
| 52 | 20:3n-3 | 1 |
| 53 | 520.5+/-87.3 | 1 |
| 54 | 54.8±7.3 | 1 |
| 55 | fe13 | 1 |
| 56 | 1-1.33 | 1 |
| 57 | pro-lc3 | 1 |
| 58 | 45,800/mm3 | 1 |
| 59 | radius2/radius3 | 1 |
| 60 | 20:3ω3 | 1 |
| 61 | 6.6±3 | 1 |
| 62 | 20/.04 | 1 |
| 63 | ich-e14 | 1 |
| 64 | 9.1/24 | 1 |
| 65 | 153.67±20.34 | 1 |
| 66 | 753.46+/-53.34 | 1 |
| 67 | €9,044 | 1 |
| 68 | lys444 | 1 |
| 69 | 0.00894 | 1 |
| 70 | 299.8±54.5 | 1 |
| 71 | 15.6±4.5 | 1 |
| 72 | 60±27.5 | 1 |
| 73 | d1/malaysia/36000/05 | 1 |
| 74 | 15+/-15 | 1 |
| 75 | 0.49±0.15 | 1 |
| 76 | 0.19±0.25 | 1 |
| 77 | j=25 | 1 |
| 78 | 90,735 | 1 |
| 79 | 1846±75 | 1 |
| 80 | €120,195 | 1 |
| 81 | δbmi≤5 | 1 |
| 82 | 8.9+/-1.6 | 1 |
| 83 | 22.8+/-29.6 | 1 |
| 84 | 6±1.06 | 1 |
| 85 | 24,206 | 1 |
| 86 | £10,926 | 1 |
| 87 | 1.0546 | 1 |
| 88 | 292,666 | 1 |
| 89 | €41,986 | 1 |
| 90 | 1.1717 | 1 |
| 91 | €12.37 | 1 |
| 92 | iso1567 | 1 |
| 93 | 1-insp7 | 1 |
| 94 | 21.4±0.8 | 1 |
| 95 | 35.2±21.8 | 1 |
| 96 | 11,261.8 | 1 |
| 97 | 7.94±1.8 | 1 |
| 98 | 4.9±2.8 | 1 |
| 99 | 18.60±1.18 | 1 |
| 100 | 1.4238 | 1 |
| 101 | 122+/-48 | 1 |
| 102 | 2.5+/-0.58 | 1 |
| 103 | 0.7668 | 1 |
| 104 | met8 | 1 |
| 105 | 153±10/83±8 | 1 |
| 106 | 14.0±11.9 | 1 |
| 107 | 118.8+/-6.9 | 1 |
| 108 | 0.84±0.09 | 1 |
| 109 | 2002/09 | 1 |
| 110 | 91,219 | 1 |
| 111 | snap29 | 1 |
| 112 | 5.89+/-0.59 | 1 |
| 113 | 3.15.1989 | 1 |
| 114 | torquing.a | 1 |
| 115 | mdma/mda | 1 |
| 116 | dyspnoea/polypnoea | 1 |
| 117 | laryngotracheomalacia | 1 |
| 118 | hyperlactaemia | 1 |
| 119 | hypercalcuria/hypercalcemia | 1 |
| 120 | hipokaliemia | 1 |
| 121 | hypoxia-hyperoxia | 1 |
| 122 | non-levodopa | 1 |
| 123 | 2000μa | 1 |
| 124 | 2-tb | 1 |
| 125 | malaria/tb | 1 |
| 126 | collec | 1 |
| 127 | cauti-specific | 3 |
| 128 | ≤71°c | 1 |
| 129 | 38±1°c | 1 |
| 130 | 310.8°c | 1 |
| 131 | 368°c | 1 |
| 132 | -0.19±0.38d | 1 |
| 133 | al-assad | 1 |
| 134 | intimal-based | 1 |
| 135 | apolipoprotein-based | 1 |
| 136 | splenectomy-based | 1 |
| 137 | n-thiophosphorylated | 1 |
| 138 | unwilted | 1 |
| 139 | tilted/twisted | 1 |
| 140 | single-gloved | 1 |
| 141 | preapproved | 1 |
| 142 | standarized | 1 |
| 143 | none-mild | 1 |
| 144 | 180-fold | 1 |
| 145 | 33.3-fold | 1 |
| 146 | 11.26-fold | 1 |
| 147 | 38.8-fold | 1 |
| 148 | rhabdoviridae | 1 |
| 149 | pseudoabsorbance | 1 |
| 150 | non-resistance | 1 |
| 151 | morning-preference | 1 |
| 152 | laulimalide | 1 |
| 153 | octatropine-methyl-bromide | 1 |
| 154 | oxymorphone-3-glucuronide | 1 |
| 155 | forge | 8 |
| 156 | graded-calorie | 1 |
| 157 | ranke | 1 |
| 158 | mild-systole | 1 |
| 159 | cotrimoxazole/sulfamethoxazole | 1 |
| 160 | self-schedule | 2 |
| 161 | arome | 1 |
| 162 | benchâabane | 1 |
| 163 | tetramesityldisilene | 1 |
| 164 | convene | 5 |
| 165 | 3-hydroxylaminonitrobenzene | 1 |
| 166 | e-line | 1 |
| 167 | d-penacillamine | 1 |
| 168 | troponine | 1 |
| 169 | hydrochloroquine | 1 |
| 170 | morphine/m6g/oxycodone | 1 |
| 171 | actidione | 1 |
| 172 | rosiglitzone | 1 |
| 173 | develope | 3 |
| 174 | acquire | 526 |
| 175 | endure | 61 |
| 176 | bone-pressure | 1 |
| 177 | mineralise | 1 |
| 178 | apprise | 1 |
| 179 | devise | 113 |
| 180 | self-diagnose | 11 |
| 181 | sclerose | 1 |
| 182 | self-advocate | 1 |
| 183 | eluciate | 1 |
| 184 | formulate | 312 |
| 185 | degranulate | 1 |
| 186 | 17alpha-hydroxylate | 1 |
| 187 | resveratrol/hydroxycinnamate | 1 |
| 188 | polyubiquitinate | 1 |
| 189 | pre-concentrate | 1 |
| 190 | supersaturate | 1 |
| 191 | malate/pyruvate | 1 |
| 192 | lee-white | 1 |
| 193 | lute | 3 |
| 194 | ttv-negative | 1 |
| 195 | survive | 705 |
| 196 | self-evolve | 1 |
| 197 | graze | 11 |
| 198 | politicize | 1 |
| 199 | decidualize | 1 |
| 200 | itemize | 1 |
| 201 | re-colonize | 2 |
| 202 | polymerize | 13 |
| 203 | 1,3,4-trcdf | 1 |
| 204 | 135+/-12mmhg | 1 |
| 205 | -433mmhg | 1 |
| 206 | 282mosmol/kg | 1 |
| 207 | isolator-bedding | 1 |
| 208 | tape-recording | 1 |
| 209 | drop-taking | 1 |
| 210 | cardiac-remodeling | 1 |
| 211 | onset-of-thickening | 1 |
| 212 | hand-pointing | 1 |
| 213 | 4.1-log | 1 |
| 214 | ebpg | 1 |
| 215 | u-50,488h | 1 |
| 216 | top-notch | 1 |
| 217 | c6-oh | 1 |
| 218 | ecorii | 1 |
| 219 | holldack | 1 |
| 220 | 0.309w/mk | 1 |
| 221 | theses-uk | 1 |
| 222 | 142.3±22.9μmol/l | 1 |
| 223 | electrocardiological | 1 |
| 224 | epicentral | 1 |
| 225 | amygdalostriatal | 1 |
| 226 | ventrolateral-orbitofrontal | 1 |
| 227 | meindl | 1 |
| 228 | non-nhl | 1 |
| 229 | consent/enroll | 1 |
| 230 | 0.004mg/ml | 1 |
| 231 | 22.3microg/ml | 1 |
| 232 | o-diphenol | 1 |
| 233 | uv-control | 1 |
| 234 | carbapenam | 1 |
| 235 | wet-film | 1 |
| 236 | ≤4.25mm | 1 |
| 237 | 720nm | 1 |
| 238 | tabagism | 1 |
| 239 | halstedianism | 1 |
| 240 | meichenbaum | 1 |
| 241 | ileocecum | 1 |
| 242 | 6.2μm | 1 |
| 243 | oa.australian | 1 |
| 244 | low-plan | 1 |
| 245 | landesman | 2 |
| 246 | kohistan | 1 |
| 247 | nincds-airen | 1 |
| 248 | kjelsen | 1 |
| 249 | hansten | 1 |
| 250 | breddin | 1 |
| 251 | penicilin | 1 |
| 252 | eupafolin | 1 |
| 253 | dopa-melanin | 1 |
| 254 | thionin | 1 |
| 255 | lactofuchsin | 1 |
| 256 | pre-agreed-on | 1 |
| 257 | neuroimmune-modulation | 1 |
| 258 | appetite-regulation | 1 |
| 259 | metainflammation | 1 |
| 260 | motor-preparation | 1 |
| 261 | over-condensation | 1 |
| 262 | malfermentation | 1 |
| 263 | devernalization | 1 |
| 264 | hyposenzibilization | 1 |
| 265 | ondensetron | 2 |
| 266 | guanaco | 1 |
| 267 | mcd/oo | 1 |
| 268 | gumboro | 1 |
| 269 | 10217euro | 1 |
| 270 | trm.sponsorship | 1 |
| 271 | develop | 9,576 |
| 272 | 'develop | 1 |
| 273 | identify/develop | 1 |
| 274 | deltapn/year | 1 |
| 275 | hucr | 2 |
| 276 | schroeder | 1 |
| 277 | recover | 694 |
| 278 | 677cc-mthfr | 1 |
| 279 | windfuhr | 1 |
| 280 | actn3rr | 1 |
| 281 | volatile-sulfur | 1 |
| 282 | 494°/s | 1 |
| 283 | antiallergenics | 1 |
| 284 | 48-h-olds | 1 |
| 285 | 11-month-olds | 1 |
| 286 | 23-month-olds | 1 |
| 287 | microaerophiles | 1 |
| 288 | dna-molecules | 1 |
| 289 | fluoroquinolnes | 1 |
| 290 | cinolones | 1 |
| 291 | cycloalkanones | 1 |
| 292 | isatin-3-hydrazones | 1 |
| 293 | hothouses | 1 |
| 294 | nanoviruses | 1 |
| 295 | dropout-rates | 1 |
| 296 | mammopoiesis | 1 |
| 297 | addresssepsis | 1 |
| 298 | peri-insulitis | 1 |
| 299 | 5beta-pregnane-3alpha/3beta,17alpha,20alpha-triols | 1 |
| 300 | paleo-indians | 1 |
| 301 | α-expansins | 1 |
| 302 | gp-consultations | 1 |
| 303 | non-ctos | 1 |
| 304 | intense-relationships | 1 |
| 305 | fg-nups | 1 |
| 306 | 100years | 1 |
| 307 | non-planners | 1 |
| 308 | injecting-drug-users | 1 |
| 309 | granddaughters | 1 |
| 310 | five-layers | 1 |
| 311 | jass | 1 |
| 312 | overtidiness | 1 |
| 313 | anxiety/calmness | 1 |
| 314 | pregnancy-loss | 1 |
| 315 | help/interact | 1 |
| 316 | hydrodissect | 1 |
| 317 | inherit | 23 |
| 318 | post-imt | 1 |
| 319 | tlr5-independent | 1 |
| 320 | pharmaco-treatment | 1 |
| 321 | interpathologist | 1 |
| 322 | encrust | 4 |
| 323 | chalumeau | 1 |
| 324 | 3wu | 1 |
| 325 | 40.4ppmv | 1 |
| 326 | 4s-pathway | 1 |
| 327 | screen/identify | 1 |
| 328 | classifiy | 1 |
| 329 | zipursky | 1 |
| 330 | laser/cryotherapy | 1 |
| 331 | peoscopy | 1 |
| 332 | automimicry | 1 |
| 333 | time-to-recovery | 1 |
| 334 | remarry | 1 |
| 335 | tossy | 1 |
| 336 | placebo.low-quality | 1 |
| 337 | viviparity | 1 |
| 338 | 1.0z | 1 |
| 339 | hurwitz | 1 |
| 340 | hotz | 1 |
| 341 | cab₆ | 1 |
| 342 | diskus™ | 1 |
| 343 | aché | 1 |
| 344 | -23.7‰ | 1 |
| 345 | 60.6° | 1 |
| 346 | 20.7° | 1 |
| 347 | 1949» | 1 |